Pharmacotherapy of canine atopic dermatitis - current state and new trends

dc.contributor.authorBÄUMER, Wolfgang
dc.contributor.departmentVeteriner Fakültesitr_TR
dc.date.accessioned2021-10-07T11:14:46Z
dc.date.available2021-10-07T11:14:46Z
dc.date.issued2019-12-26
dc.description.abstractThis review offers a concise overview of current treatment options for canine atopic dermatitis and provide an outline of two promising new treatment options (phosphodiesterase 4 and histamine H4 receptor inhibitors). Glucocorticoids have been one of the first successful treatment options and are still part of the treatment regime. Ciclosporin was introduced more than 15 years ago and is also a main pharmacological treatment option. In 2013, the Janus kinase inhibitor oclacitinib was introduced as a first in class, which is then followed by the anti-canine IL-31 antibody lokivetmab in 2016. Thus, exciting new treatment options have found their way into clinical practice. Apart from these substance classes, antihistamines, essential fatty acids and lipid substitution will be discussed as add-on treatments.tr_TR
dc.identifier.endpage111tr_TR
dc.identifier.issn/e-issn1308-2817
dc.identifier.issue1tr_TR
dc.identifier.startpage107tr_TR
dc.identifier.urihttps://doi.org/10.33988/auvfd.644485tr_TR
dc.identifier.urihttp://hdl.handle.net/20.500.12575/75310
dc.identifier.volume67tr_TR
dc.language.isoentr_TR
dc.publisherAnkara Üniversitesitr_TR
dc.relation.isversionof10.33988/auvfd.644485tr_TR
dc.relation.journalAnkara Üniversitesi Veteriner Fakültesi Dergisitr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıtr_TR
dc.subjectAtopic dermatitistr_TR
dc.subjectPharmacotherapytr_TR
dc.subjectDogtr_TR
dc.titlePharmacotherapy of canine atopic dermatitis - current state and new trendstr_TR
dc.typeArticletr_TR

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
45.pdf
Size:
376.79 KB
Format:
Adobe Portable Document Format
Description:
Dergi
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.62 KB
Format:
Item-specific license agreed upon to submission
Description: